These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
16. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Listernick R; Ferner RE; Liu GT; Gutmann DH Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm. Caen S; Cassiman C; Legius E; Casteels I Eur J Paediatr Neurol; 2015 Jul; 19(4):415-22. PubMed ID: 25797697 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas. Marjanska A; Kubicka M; Kurylo-Rafinska B; Jatczak-Gaca A; Wysocki M; Styczynski J Anticancer Res; 2019 Nov; 39(11):6389-6392. PubMed ID: 31704872 [TBL] [Abstract][Full Text] [Related]
19. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226 [TBL] [Abstract][Full Text] [Related]
20. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]